[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573821":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":22,"centralContacts":26,"locations":22,"responsibleParty":32,"collaborators":22,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":22,"eligibilityCriteria":41,"healthyVolunteers":38,"sex":42,"minAge":43,"maxAge":44,"enrollmentInfo":45,"targetDuration":22,"studyType":48,"phases":49,"briefSummary":51,"conditions":52,"keywords":22,"overallStatus":54,"whyStopped":22,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":22},{"fullName":5,"class":6},"Peking University Aerospace Center Hospital","OTHER",[8,13],{"label":9,"type":10,"description":9,"interventionNames":11},"Peritoneal water isolation","EXPERIMENTAL",[12],"Procedure: Peritoneal water isolation",{"label":14,"type":10,"description":14,"interventionNames":15},"Peritoneal combined with intrauterine water isolation",[16],"Procedure: Peritoneal combined with intrauterine water isolation",[18,23],{"type":19,"name":14,"description":20,"armGroupLabels":21,"otherNames":22},"PROCEDURE","On the basis of the conventional peritoneal water isolation group, the improved technology group added additional intrauterine water isolation, and continued to inject ice saline to separate the endometrium on both sides.",[14],null,{"type":19,"name":9,"description":24,"armGroupLabels":25,"otherNames":22},"Transabdominal injection of saline into the abdominal cavity to achieve complete separation of the uterus from the surrounding organs and structures",[9],[27],{"name":28,"role":29,"phone":30,"phoneExt":22,"email":31},"Lei Liang, PHD","CONTACT","010-59971599","lianglei_csk@126.com",{"type":33,"investigatorFullName":34,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":22,"oldOrganization":22},"PRINCIPAL_INVESTIGATOR","Liang Lei","Peking University Aerospace Centre Hospital","100573821","evaluation-of-the-efficacy-and-safety-of-microwave-ablation-of-uterine-adenomyosis-under-improved-ultrasound-guidance-100573821",false,"NCT06751264","Evaluation of the Efficacy and Safety of Microwave Ablation of Uterine Adenomyosis Under Improved Ultrasound Guidance","Inclusion Criteria:\n\n1. UFs or AM diagnosed by pathology and ultrasound；\n2. Relevant symptoms such asabnormal uterine bleeding, secondary anemia, progressive dysmenorrhea and enlargement of the uterus；\n3. Voluntarily undergo MWA；\n4. a confirmed available safe transabdominal puncture path；\n\nExclusion Criteria:\n\n1. Pregnancy or malignancy；\n2. Severe and uncorrectable coagulation disorders；\n3. Severe cardiac, liver, and renal dysfunction；\n4. Anesthesia allergy.","FEMALE","18 Years","60 Years",{"count":46,"type":47},137,"ESTIMATED","INTERVENTIONAL",[50],"NA","This study aims to compare the safety and efficacy of segmental power adjustment combined with uterine cavity hydro-isolation in microwave ablation of adenomyosis",[53],"Adenomyosis of Uterus","NOT_YET_RECRUITING","2024-12-20",{"date":57,"type":58},"2024-12-27","ACTUAL",{"date":60,"type":47},"2025-01-01",{"date":62,"type":47},"2027-12-31",{"name":5,"class":6}]